$SBUX Options Intelligence

🎯 SELL SBUX MAR 20 100/105 CALL SPREAD

I recommend this credit spread because the term structure reveals significant overpricing in near-term options. The 14-day Clean IV of 41.3% sits 12.4% above the 28.9% baseline volatility, creating a premium-selling opportunity. Combined with SBUX's RSI at 52.84 (neutral, not overbought) and the stock trading essentially flat to its 20-day MA at 96.48, this setup favors collecting premium from overpriced calls while the stock consolidates ahead of earnings on May 5th.

SELL SBUX Mar 20 100/105 Call Spread
Stock Price: $96.47 | Entry: $0.45 credit

📊 Trade Metrics

• Risk: $455 (width of spread minus credit received)
• Reward: $45 (credit collected)
• Breakeven: $100.45
• Max Profit: $45 if SBUX < $100 at expiry
• Max Loss: $455 if SBUX > $105 at expiry
• Win Rate: 68% (based on delta)
• Days to Expiration: 18

📈 Term Structure & Volatility Analysis

• Baseline 90-day Vol: 28.9%
• 14-day Clean IV: 41.3% (12.4% OVERPRICED = SELL signal)
• Market IV: 44.7% (elevated event premium)
• Current IV Rank: 94% (Extremely high - strong sell premium bias)
• Earnings Multiplier: 5.23x (very high expected volatility at May 5 earnings)
• Calendar Opportunity: Significant IV compression between March and June expirations creates a strong sell-near, buy-far dynamic

The March 20 expiration is perfectly positioned before earnings (May 5), allowing you to collect inflated pre-earnings premium while avoiding the earnings event risk entirely. The 41.3% Clean IV is substantially above the 28.9% baseline, indicating options are priced for volatility that won't materialize before expiration.

📈 Greeks & Volatility

• Net Delta: 0.23 (slightly bullish bias, but contained)
• Theta: $8/day (strong time decay in your favor)
• Vega: -$12 (benefits from IV compression)
• Current IV: 44.7% vs Historical: 29.9%
• IV Rank: 94% (Extremely elevated - sell premium favored)
• Put/Call Ratio: 0.47 (very bullish sentiment, calls overpriced)

🎯 Why This Trade

The term structure is screaming "SELL" here. At 41.3% Clean IV, March options are priced 12.4% above the 28.9% baseline—this is extreme overpricing. The IV Rank of 94% confirms we're at historically elevated levels. Analysts maintain a "Moderate Buy" consensus with a $104.31 price target, but that's 8% above current price, and the stock has shown mixed momentum—it opened at $98.02 but is now at $96.47, down 1.58%[1][2].

The recent Q1 earnings miss ($0.56 vs $0.59 expected) combined with FY2026 guidance of $2.15–$2.40 EPS has already been digested by the market[1][4]. With earnings not until May 5, there's no major catalyst to drive SBUX above $105 in the next 18 days. The stock's RSI at 52.84 is neutral (not overbought), and it's trading right at its 20-day MA—classic consolidation pattern. The 100 strike is 3.7% above current price (reasonable buffer), while the 105 strike is 8.9% away (very safe). This spread captures the premium decay while limiting risk.

📊 Pro Analysis

• Current IV: 44.7% vs Historical: 29.9% (+49% premium)
• IV Rank: 94% (Extreme - highest quartile)
• Expected Daily Move: ±$2.14 (2.22%)
• Put/Call Ratio: 0.47 (calls heavily bought, overpriced)
• Market Maker Max Pain: $100 (43,428 contracts)
• Technical: RSI 52.84 (neutral), Price at 20MA, no overbought condition
• Unusual Activity: 115 put showing 3.1x normal volume (hedging interest)

🔍 Earnings Date Check

Earnings on May 5, 2026 | Recommended expiration: March 20, 2026 | ✅ SAFE: Expires 46 days BEFORE earnings — This is intentional. You're collecting premium from pre-earnings IV inflation without exposure to the earnings event itself. After March 20 expiration, if you want to play earnings, you can roll into May or June expirations.

💡 Trade Management

• Entry: Place limit order at $0.45 credit (mid of $0.40/$0.50)
• Target: Close at $0.15 (67% profit) around March 13
• Stop: Exit if SBUX breaks above $102
• Time Stop: Close 3 days before March 20 expiration

📅 Economic Events This Week

• Non-Farm Payrolls: March 6 (4 days away) — Could create volatility spike; consider closing early if NFP surprises
• Consumer Price Index: March 11 (9 days away)

🔍 Market Overview

The Fed's current stance suggests stable rates through Q1 2026, supporting equity valuations. SBUX trades at a P/E of 81.01 (elevated but justified by growth expectations)[1]. The stock's 50-day MA at $92.43 and 200-day MA at $87.65 show a clear uptrend, with SBUX trading above both[1][4]. However, the recent -1.58% decline suggests profit-taking after the January earnings beat on revenue ($9.92B, up 5.5% YoY)[2]. Institutional ownership at